Y mAbs Therapeutics (YMAB) Q3 2024 Earnings

Aug 12Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.21
-0.15
-0.08
-0.02

Details

Expected EPS
-0.124286
Actual EPS
-0.21
Surprise EPS
-0.09
Surprise Percent
-68.97%

Description

⁨Y mAbs Therapeutics⁩ (⁦YMAB⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts